TG Therapeutics, Inc. (LON:0VGI)
37.50
-1.05 (-2.72%)
At close: Mar 14, 2025
TG Therapeutics Employees
TG Therapeutics had 338 employees as of December 31, 2024. The number of employees increased by 74 or 28.03% compared to the previous year.
Employees
338
Change (1Y)
74
Growth (1Y)
28.03%
Revenue / Employee
777.51K GBP
Profits / Employee
55.26K GBP
Market Cap
5.19B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Genus | 3,500 |
TG Therapeutics News
- 12 days ago - TG Therapeutics: Considering If The Promise Of Accelerated Revenue Growth Is Enough - Seeking Alpha
- 18 days ago - TG Therapeutics: Progress In MS Tempered By High Expectations - Seeking Alpha
- 20 days ago - Price Over Earnings Overview: TG Therapeutics - Benzinga
- 25 days ago - TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting - GlobeNewsWire
- 4 weeks ago - TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical Journals - GlobeNewsWire
- 4 weeks ago - IBD 50 Stock TG Therapeutics Rallies On A Setback For Chief Rival Roche - Investor's Business Daily
- 4 weeks ago - TG Therapeutics rises after trial setback for high dose version of Roche’s MS drug - Seeking Alpha
- 6 weeks ago - Stock Of The Day: TG Therapeutics Breaks Out, May Head Higher - Benzinga